Sees Q4 adjusted EBITDA $21M-$23M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HROW:
- Harrow Health options imply 17.9% move in share price post-earnings
- Harrow launches Vevye Access for All
- HROW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Harrow executes five-year supply, development agreement for Triesence
- Reddit initiated, Cigna downgraded: Wall Street’s top analyst calls